Regulation of maturation and activating potential in CD8+ versus CD8- dendritic cells following in vivo infection with vaccinia virus

Virology

Volumn 378, Issue 1, 2008, Pages 142-150

  Yammani, Rama D ^a   Pejawar Gaddy, Sharmila ^a   Gurley, Thaddeus C ^a,b   Weimer, Eric T ^a   Hiltbold, Elizabeth M ^a   Alexander Miller, Martha A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antigen presentation; Costimulatory molecule; Dendritic cell; Maturation; VAccinia virus

Indexed keywords

CD8 ANTIGEN; CYTOKINE; INTERLEUKIN 12; MYELOID DIFFERENTIATION FACTOR 88;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL MATURATION; CELL SUBPOPULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYSTEMIC DISEASE; UPREGULATION; VACCINIA; VACCINIA VIRUS;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD8; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DENDRITIC CELLS; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MYELOID DIFFERENTIATION FACTOR 88; VACCINIA VIRUS;

VACCINIA VIRUS;

EID: 47749139258     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.05.031     Document Type: Article

References (39)

1. Akira S., Hoshino K., and Kaisho T. The role of Toll-like receptors and MyD88 in innate immune responses. J. Endotoxin Res. 6 (2000) 383-387
2. Alcami A., and Koszinowski U.H. Viral mechanisms of immune evasion. Trends Microbiol. 8 (2000) 410-418
3. Baeuerle P.A., and Henkel T. Function Amd Activation of Nf-Kappa-B in the Immune-System. Annu. Rev. Immunol. 12 (1994) 141-179
4. + T cells. J. Immunol. 168 (2002) 5403-5408
5. Beattie E., Tartaglia J., and Paoletti E. Vaccinia virus-encoded eIF-2 alpha homolog abrogates the antiviral effect of interferon. Virology 183 (1991) 419-422
6. Bekeredjian-Ding I., Roth S.I., Gilles S., Giese T., Ablasser A., Hornung V., Endres S., and Hartmann G. T cell-independent, TLR-induced IL-12p70 production in primary human monocytes. J. Immunol. 176 (2006) 7438-7446
7. Belz G.T., Smith C.M., Eichner D., Shortman K., Karupiah G., Carbone F.R., and Heath W.R. Cutting edge: conventional CD8 alpha+dendritic cells are generally involved in priming CTL immunity to viruses. J. Immunol. 172 (2004) 1996-2000
8. Bowie A., Kiss-Toth E., Symons J.A., Smith G.L., Dower S.K., and O'Neill L.A.J. A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc. Natl. Acad. Sci. USA 97 (2000) 10162-10167
9. Chang H.W., Watson J.C., and Jacobs B.L. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc. Natl. Acad. Sci. USA 89 (1992) 4825-4829
10. Curtsinger J.M., Johnson C.M., and Mescher M.F. CD8 T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine. J. Immunol. 171 (2003) 5165-5171
11. Curtsinger J.M., Valenzuela J.O., Agarwal P., Lins D., and Mescher M.F. Cutting edge: Type IIFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol. 174 (2005) 4465-4469
12. Drillien R., Spehner D., Bohbot A., and Hanau D. Vaccinia virus-related events and phenotypic changes after infection of dendritic cells derived from human monocytes. Virology 268 (2000) 471-481
13. Edwards A.D., Diebold S.S., Slack E.M., Tomizawa H., Hemmi H., Kaisho T., Akira S., and Reis e S. Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+DC correlates with unresponsiveness to imidazoquinolines. Eur. J. Immunol 33 (2003) 827-833
14. Engelmayer J., Larsson M., Subklewe M., Chahroudi A., Cox W.I., Steinman R.M., and Bhardwaj N. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J. Immunol. 163 (1999) 6762-6768
15. Fung-Leung W.P., Schilham M.W., Rahemtulla A., Kundig T.M., Vollenweider M., Potter J., van Ewijk W., and Mak T.W. CD8 is needed for development of cytotoxic T cells but not helper T cells. Cell 65 (1991) 443-449
16. Harte M.T., Haga I.R., Maloney G., Gray P., Reading P.C., Bartlett N.W., Smith G.L., Bowie A., and O'Neill L.A.J. The poxvirus protein A52R targets toll-like receptor signaling complexes to suppress host defense. J. Exp. Med. 197 (2003) 343-351
17. +T cells responding to self-antigens. J. Exp. Med. 196 (2002) 323-333
18. Hickman H.D., Takeda K., Skon C.N., Murray F.R., Hensley S.E., Loomis J., Barber G.N., Bennink J.R., and Yewdell J.W. Direct priming of antiviral CD8+ T cells in the peripheral interfollicular region of lymph nodes. Nat. Immunol. 9 (2008) 155-165
19. Hoebe K., Du X., Georgel P., Janssen E., Tabeta K., Kim S.O., Goode J., Lin P., Mann N., Mudd S., Crozat K., Sovath S., Han J., and Beutler B. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424 (2003) 743-748
20. Hogquist K.A., Jameson S.C., Heath W.R., Howard J.L., Bevan M.J., and Carbone F.R. T cell receptor antagonist peptides induce positive selection. Cell 76 (1994) 17-27
21. Kawai T., Adachi O., Ogawa T., Takeda K., and Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11 (1999) 115-122
22. Macagno A., Napolitani G., Lanzavecchia A., and Sallusto F. Duration, combination and timing: the signal integration model of dendritic cell activation. Trends Immunol. 28 (2007) 227-233
23. Mombaerts P., Iacomini J., Johnson R.S., Herrup K., Tonegawa S., and Papaioannou V.E. Rag-1-deficient mice have no mature lymphocytes-B and lymphocytes-T. Cell 68 (1992) 869-877
24. + T cells by infected dendritic cells in vivo. Nat. Immunol. 3 (2002) 265-271
25. Onomoto K., Yoneyama M., and Fujita T. Regulation of antiviral innate immune responses by RIG-I family of RNA helicases. Curr. Top. Microbiol. Immunol. 316 (2007) 193-205
26. Paez E., and Esteban M. Nature and mode of action of vaccinia virus products that block activation of the interferon-mediated Ppp(A2'P)Na-synthetase. Virology 134 (1984) 29-39
27. Pejawar-Gaddy S., and Alexander-Miller M.A. Ligation of CD80 is critical for high-level CD25 expression on CD8+T lymphocytes. J. Immunol. 177 (2006) 4495-4502
28. Princiotta M.F., Finzi D., Qian S.B., Gibbs J., Schuchmann S., Buttgereit F., Bennink J.R., and Yewdell J.W. Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 18 (2003) 343-354
29. Schulz O., Edwards A.D., Schito M., Aliberti J., Manickasingham S., Sher A., and Reis e S. CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 13 (2000) 453-462
30. Seet B.T., Johnston J.B., Brunetti C.R., Barrett J.W., Everett H., Cameron C., Sypula J., Nazarian S.H., Lucas A., and McFadden G. Poxviruses and immune evasion. Annu. Rev. Immunol. 21 (2003) 377-423
31. Sen R., and Baltimore D. Inducibility of kappa-immunoglobulin enhancer-binding protein Nf-kappa-B by a posttranslational mechanism. Cell 47 (1986) 921-928
32. Sen R., and Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46 (1986) 705-716
33. + CTL following exposure to vaccinia virus via different routes. J. Immunol. 169 (2002) 4222-4229
34. Stack J., Haga I.R., Schroder M., Bartlett N.W., Maloney G., Reading P.C., Fitzgerald K.A., Smith G.L., and Bowie A.G. Vaccinia virus protein Toll-like-interleukin-1 A46R targets multiple receptor adaptors and contributes to virulence. J. Exp. Med. 201 (2005) 1007-1018
35. Takaoka A., Wang Z., Choi M.K., Yanai H., Negishi H., Ban T., Lu Y., Miyagishi M., Kodama T., Honda K., Ohba Y., and Taniguchi T. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448 (2007) 501-505
36. van den Broek M.F., Bachmann M.F., Kohler G., Barner M., Escher R., Zinkernagel R., and Kopf M. IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-gamma and nitric oxide synthetase 2. J. Immunol. 164 (2000) 371-378
37. Xiang Y., Condit R.C., Vijaysri S., Jacobs B., Williams B.R.G., and Silverman R.H. Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus. J. Virol. 76 (2002) 5251-5259
38. Yates N.L., and Alexander-Miller M.A. Vaccinia virus infection of mature dendritic cells results in activation of virus-specific naive CD8+ T cells: a potential mechanism for direct presentation. Virology 359 (2007) 349-361
39. Zhu J., Martinez J., Huang X., and Yang Y. Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta. Blood 109 (2007) 619-625